Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019
05:35pm, Wednesday, 19'th Feb 2020
PORTLAND, Maine, Feb. 19, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.
24 Stocks Moving in Wednesday's Pre-Market Session
12:29pm, Wednesday, 19'th Feb 2020
Gainers
Viveve Medical, Inc (NASDAQ: VIVE) shares rose 22.8% to $1.67 in pre-market trading after climbing 15.25% on Tuesday.
Shotspotter Inc (NASDAQ: SSTI) shares rose 20.1% to...
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the … Full story available on Benzinga.com
ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($…. ...
12:00am, Wednesday, 19'th Feb 202012 Stocks Moving In Tuesday's After-Hours Session
09:59pm, Tuesday, 18'th Feb 2020
Gainers
ShotSpotter (NASDAQ: SSTI) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also reaffirmed FY20...
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
09:05pm, Tuesday, 18'th Feb 2020
PORTLAND, Maine, Feb. 18, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.
ImmuCell shares are trading higher after the company reported Q4 EPS and sales were up from the same quarter last year.
12:00am, Tuesday, 18'th Feb 2020The Week Ahead In Biotech: Agile, Baudax Bio, Merck and Esperion Await FDA Decisions
08:03pm, Sunday, 16'th Feb 2020
Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies. The following are key biotech catalysts to look
ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019
02:17pm, Thursday, 13'th Feb 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im
The Wuhan Coronavirus: 21 Stocks to Watch
05:00pm, Wednesday, 29'th Jan 2020
News like the Coronavirus can affect the stock market — either as a whole or just certain stocks and sectors. See how you can prepare.
Why I Love Trading A Small Account, And Why You Should Too
05:04pm, Friday, 24'th Jan 2020
January is turning out to be a bit of a roller-coaster market for my main account. The last trade I took in the account on Wednesday in Neurotrope, Inc. (NASDAQ: NTRP) ended up netting me another $16
Imagine Owning ImmuCell (NASDAQ:ICCC) And Wondering If The 32% Share Price Slide Is Justified
01:35pm, Friday, 24'th Jan 2020
Investors can approximate the average market return by buying an index fund. While individual stocks can be big...
